153 related articles for article (PubMed ID: 11159506)
1. Acquired activated protein C resistance is associated with lupus anticoagulants and thrombotic events in pediatric patients with systemic lupus erythematosus.
Male C; Mitchell L; Julian J; Vegh P; Joshua P; Adams M; David M; Andrew ME
Blood; 2001 Feb; 97(4):844-9. PubMed ID: 11159506
[TBL] [Abstract][Full Text] [Related]
2. [Relationship between phenomenon of acquired activated protein C resistance and antiphospholipid antibodies in patients with systemic lupus erythematosus].
Hu YQ; Chen FP; Xie QZ
Hunan Yi Ke Da Xue Xue Bao; 2001 Oct; 26(5):469-72. PubMed ID: 12536506
[TBL] [Abstract][Full Text] [Related]
3. Activated protein C resistance and lupus anticoagulant activity induced by plasma and purified monospecific human IgG anti-beta2-glycoprotein-I antibodies.
Viveros ME; Cabiedes J; Reyes E; Cabral AR
Rev Invest Clin; 2005; 57(4):563-71. PubMed ID: 16315641
[TBL] [Abstract][Full Text] [Related]
4. The contribution of inherited and acquired thrombophilic defects, alone or combined with antiphospholipid antibodies, to venous and arterial thromboembolism in patients with systemic lupus erythematosus.
Brouwer JL; Bijl M; Veeger NJ; Kluin-Nelemans HC; van der Meer J
Blood; 2004 Jul; 104(1):143-8. PubMed ID: 15026314
[TBL] [Abstract][Full Text] [Related]
5. Anti-protein C antibodies and acquired protein C resistance in SLE: novel markers for thromboembolic events and disease activity?
Ramirez GA; Mackie I; Nallamilli S; Pires T; Moll R; Pericleous C; Isenberg DA; Cohen H; Efthymiou M
Rheumatology (Oxford); 2021 Mar; 60(3):1376-1386. PubMed ID: 32964932
[TBL] [Abstract][Full Text] [Related]
6. [Thrombophilia in systemic lupus erythematosus: A case-control study].
Belfeki N; Khanfir MS; Said F; Houman MH
J Med Vasc; 2018 Dec; 43(6):347-353. PubMed ID: 30522706
[TBL] [Abstract][Full Text] [Related]
7. Predictive value of persistent versus transient antiphospholipid antibody subtypes for the risk of thrombotic events in pediatric patients with systemic lupus erythematosus.
Male C; Foulon D; Hoogendoorn H; Vegh P; Silverman E; David M; Mitchell L
Blood; 2005 Dec; 106(13):4152-8. PubMed ID: 16144797
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of acquired activated protein C resistance in patients with systemic lupus erythematosus.
Muñoz-Rodríguez FJ; Reverter JC; Font J; Tàssies D; Espinosa G; Cervera R; Carmona F; Balsch J; Ingelmo M; Ordinas A
Lupus; 2002; 11(11):730-5. PubMed ID: 12475003
[TBL] [Abstract][Full Text] [Related]
9. Acquired activated protein C resistance, high tissue factor expression, and hyper-homocysteinemia in systemic lupus erythematosus.
Oh D; Kim SH; Kang MS; Kim NK; Chang NS; Na BW; Chung SY; Park S; Cho CS
Am J Hematol; 2003 Feb; 72(2):103-8. PubMed ID: 12555213
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of role of FV, FVIII and APLAs in the pathogenesis of APCR in FV Leiden negative DVT patients: a study in India.
Sharma A; Singh K; Biswas A; Ranjan R; Kishor K; Kumar R; Pandey H; Kamal VK; Saxena R
J Thromb Thrombolysis; 2017 Feb; 43(2):217-223. PubMed ID: 28063132
[TBL] [Abstract][Full Text] [Related]
11. Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature.
Galli M; Luciani D; Bertolini G; Barbui T
Blood; 2003 Mar; 101(5):1827-32. PubMed ID: 12393574
[TBL] [Abstract][Full Text] [Related]
12. Clinical importance of positive test results for lupus anticoagulant and anticardiolipin antibodies.
Proven A; Bartlett RP; Moder KG; Chang-Miller A; Cardel LK; Heit JA; Homburger HA; Petterson TM; Christianson TJ; Nichols WL
Mayo Clin Proc; 2004 Apr; 79(4):467-75. PubMed ID: 15065611
[TBL] [Abstract][Full Text] [Related]
13. Acquired activated protein C resistance is associated with the co-existence of anti-prothrombin antibodies and lupus anticoagulant activity in patients with systemic lupus erythematosus.
Nojima J; Kuratsune H; Suehisa E; Kawasaki T; Machii T; Kitani T; Iwatani Y; Kanakura Y
Br J Haematol; 2002 Aug; 118(2):577-83. PubMed ID: 12139749
[TBL] [Abstract][Full Text] [Related]
14. Acquired activated protein C resistance is associated with IgG antibodies to protein S in patients with systemic lupus erythematosus.
Nojima J; Iwatani Y; Ichihara K; Tsuneoka H; Ishikawa T; Yanagihara M; Takano T; Hidaka Y
Thromb Res; 2009 May; 124(1):127-31. PubMed ID: 19128822
[TBL] [Abstract][Full Text] [Related]
15. Acquired activated protein C resistance caused by lupus anticoagulants.
Saenz AJ; Johnson NV; Van Cott EM
Am J Clin Pathol; 2011 Sep; 136(3):344-9. PubMed ID: 21846908
[TBL] [Abstract][Full Text] [Related]
16. A possible role for activated protein C resistance in patients with first and second trimester pregnancy failure.
Tal J; Schliamser LM; Leibovitz Z; Ohel G; Attias D
Hum Reprod; 1999 Jun; 14(6):1624-7. PubMed ID: 10357988
[TBL] [Abstract][Full Text] [Related]
17. Thrombotic events in systemic lupus erythematosus. Its association with acquired and inherited thrombophilic defects.
Vayá A; Santaolaria M; Micó L; Calvo J; Oropesa R; Villa P; Todoli J; Simó M; Corella D; Ricart JM
Clin Hemorheol Microcirc; 2008; 40(2):79-87. PubMed ID: 19029633
[TBL] [Abstract][Full Text] [Related]
18. Antiphospholipid antibodies and thrombosis: association with acquired activated protein C resistance in venous thrombosis and with hyperhomocysteinemia in arterial thrombosis.
Kassis J; Neville C; Rauch J; Busque L; Chang ER; Joseph L; Le Comte M; Subang R; Fortin PR
Thromb Haemost; 2004 Dec; 92(6):1312-9. PubMed ID: 15583739
[TBL] [Abstract][Full Text] [Related]
19. Multilaboratory testing of thrombophilia: current and past practice in Australasia as assessed through the Royal College of Pathologists of Australasia Quality Assurance Program for Hematology.
Favaloro EJ; Bonar R; Sioufi J; Wheeler M; Low J; Aboud M; Duncan E; Smith J; Exner T; Lloyd J; Marsden K;
Semin Thromb Hemost; 2005 Feb; 31(1):49-58. PubMed ID: 15706475
[TBL] [Abstract][Full Text] [Related]
20. The relationship of antiphospholipid antibodies to thromboembolic events in pediatric patients with systemic lupus erythematosus: a cross-sectional study.
Berube C; Mitchell L; Silverman E; David M; Saint Cyr C; Laxer R; Adams M; Vegh P; Andrew M
Pediatr Res; 1998 Sep; 44(3):351-6. PubMed ID: 9727712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
